Dr. Lasika Seneviratne
Claim this profileLos Angeles Hematology Oncology Medical Group
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
8 reported clinical trials
19 drugs studied
Affiliated Hospitals
Clinical Trials Lasika Seneviratne is currently running
SPd vs EloPd Chemotherapy
for Multiple Myeloma
This phase 3 randomized, open-label multicenter trial will compare the efficacy, safety and the impact on health-related quality of life (HR-QoL) of SPd versus EloPd in pomalidomide-naïve patients with MM who have received 1 to 4 prior anti-MM regimens and been treated with an immunomodulatory imide drug (IMiD), proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody (mAb).
Recruiting2 awards Phase 318 criteria
Novel Immunotherapy Combinations
for Lung Cancer
This study will evaluate the efficacy, safety, pharmacokinetics (PK), and pharmacodynamics (PDy) of novel immunotherapy combinations compared with immunotherapy monotherapy in participants with Programmed death ligand-1 (PD L-1) high (Tumor cells \[TC\]/ Tumor proportion score \[TPS\] ≥ 50%), previously untreated, unresectable, locally advanced or metastatic NSCLC. Drug name mentioned as Belrestotug, GSK4428859A, and EOS884448 are all interchangeable for the same compound. In the rest of the document, the drug will be referred to as Belrestotug.
Recruiting1 award Phase 28 criteria
More about Lasika Seneviratne
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Lasika Seneviratne has experience with
- Dexamethasone
- Pembrolizumab
- Trilaciclib
- Sacituzumab Govitecan-hziy
- CC-92480
- Carfilzomib
Breakdown of trials Lasika Seneviratne has run
Multiple Myeloma
Plasma Cell Neoplasms
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lasika Seneviratne specialize in?
Lasika Seneviratne focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Lasika Seneviratne currently recruiting for clinical trials?
Yes, Lasika Seneviratne is currently recruiting for 4 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Lasika Seneviratne has studied deeply?
Yes, Lasika Seneviratne has studied treatments such as Dexamethasone, Pembrolizumab, Trilaciclib.
What is the best way to schedule an appointment with Lasika Seneviratne?
Apply for one of the trials that Lasika Seneviratne is conducting.
What is the office address of Lasika Seneviratne?
The office of Lasika Seneviratne is located at: Los Angeles Hematology Oncology Medical Group, Los Angeles, California 90017 United States. This is the address for their practice at the Los Angeles Hematology Oncology Medical Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.